6-K Filing

TEVA PHARMACEUTICAL INDUSTRIES LTD CIK: 818686 Q1 2017

Filing Information

Form Type	6-K
Accession Number	`0001193125-17-167273`
Period End Date	20170331
Filing Date	20170511
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	teva-20170401.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 45 Cash Flow Statement 67 Comprehensive Income 19

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$900.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.96B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$7.52B	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$7.26B	USD	Point-in-time
Inventories	`InventoryNet`	$4.95B	USD	Point-in-time
Inventories	`InventoryNet`	$5.00B	USD	Point-in-time
Assets Held For Sale	`AssetsHeldForSale`	$841.00M	USD	Point-in-time
Assets Held For Sale	`AssetsHeldForSale`	$43.00M	USD	Point-in-time
Prepaid Expenses	`PrepaidExpenses`	$1.36B	USD	Point-in-time
Prepaid Expenses	`PrepaidExpenses`	$960.00M	USD	Point-in-time
Other Current Assets	`OtherCurrentAssets`	$669.00M	USD	Point-in-time
Other Current Assets	`OtherCurrentAssets`	$1.29B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.96B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.84B	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.32B	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.24B	USD	Point-in-time
Deferred Income Taxes	`NonCurrentDeferredIncomeTaxes`	$725.00M	USD	Point-in-time
Deferred Income Taxes	`NonCurrentDeferredIncomeTaxes`	$747.00M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$8.07B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$8.16B	USD	Point-in-time
Identifiable intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$21.19B	USD	Point-in-time
Identifiable intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$21.49B	USD	Point-in-time
Goodwill	`Goodwill`	$44.41B	USD	Point-in-time
Goodwill	`Goodwill`	$45.03B	USD	Point-in-time
Total assets	`Assets`	$91.28B	USD	Point-in-time
Total assets	`Assets`	$92.89B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$3.28B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.94B	USD	Point-in-time
Sales Reserves And Allowances	`SalesReservesAndAllowances`	$7.84B	USD	Point-in-time
Sales Reserves And Allowances	`SalesReservesAndAllowances`	$7.50B	USD	Point-in-time
Trade payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.16B	USD	Point-in-time
Trade payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.38B	USD	Point-in-time
Employee Related Obligations	`EmployeeRelatedObligations`	$859.00M	USD	Point-in-time
Employee Related Obligations	`EmployeeRelatedObligations`	$660.00M	USD	Point-in-time
Accrued Expenses	`AccruedExpenses`	$3.40B	USD	Point-in-time
Accrued Expenses	`AccruedExpenses`	$2.50B	USD	Point-in-time
Liabilities Held For Sale	`LiabilitiesOfAssetsHeldForSales`	-	USD	Point-in-time
Liabilities Held For Sale	`LiabilitiesOfAssetsHeldForSales`	$116.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$923.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$867.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.90B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.52B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$5.29B	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$5.21B	USD	Point-in-time
Other taxes and long term liabilities	`OtherLiabilitiesNoncurrent`	$1.64B	USD	Point-in-time
Other taxes and long term liabilities	`OtherLiabilitiesNoncurrent`	$1.64B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$32.69B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$32.52B	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$39.63B	USD	Point-in-time
Total long term liabilities	`LiabilitiesNoncurrent`	$39.38B	USD	Point-in-time
Total liabilities	`Liabilities`	$55.53B	USD	Point-in-time
Total liabilities	`Liabilities`	$57.90B	USD	Point-in-time
Preferred Shares	`PreferredStockValue`	$3.62B	USD	Point-in-time
Preferred Shares	`PreferredStockValue`	$3.62B	USD	Point-in-time
Ordinary shares	`CommonStockValue`	$54.00M	USD	Point-in-time
Ordinary shares	`CommonStockValue`	$54.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.41B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.41B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$13.61B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$13.81B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.16B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.71B	USD	Point-in-time
Treasury shares	`TreasuryStockValue`	$4.16B	USD	Point-in-time
Treasury shares	`TreasuryStockValue`	$4.19B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$33.34B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$34.02B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.66B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.72B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$34.99B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.74B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$92.89B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$91.28B	USD	Point-in-time

Income Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`SalesRevenueNet`	$4.81B	USD	1 Quarter
Net revenues	`SalesRevenueNet`	$5.63B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.81B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$2.02B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.79B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.82B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$457.00M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$389.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$839.00M	USD	1 Quarter
Selling and marketing expenses	`SellingAndMarketingExpense`	$971.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$236.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$304.00M	USD	1 Quarter
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$119.00M	USD	1 Quarter
Impairments restructuring and others	`ImpairmentsRestructuringAndOthers`	$240.00M	USD	1 Quarter
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$-25.00M	USD	1 Quarter
Legal Settlements And Loss Contingencies	`LegalSettlementsAndLossContingencies`	$20.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$895.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$1.17B	USD	1 Quarter
Financial expenses - net	`NonoperatingIncomeExpense`	$-298.00M	USD	1 Quarter
Financial expenses - net	`NonoperatingIncomeExpense`	$-207.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$688.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$867.00M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$54.00M	USD	1 Quarter
Income taxes	`IncomeTaxExpenseBenefit`	$228.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$7.00M	USD	1 Quarter
Share in (profits) losses of associated companies net	`IncomeLossFromEquityMethodInvestments`	$-6.00M	USD	1 Quarter
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Net income	`ProfitLoss`	$641.00M	USD	1 Quarter
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00M	USD	1 Quarter
Net income attributable to Teva	`NetIncomeLoss`	$645.00M	USD	1 Quarter
Net income attributable to Teva	`NetIncomeLoss`	$636.00M	USD	1 Quarter
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$66.00M	USD	1 Quarter
Dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$65.00M	USD	1 Quarter
Net income attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$580.00M	USD	1 Quarter
Net income attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$570.00M	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	913.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	920.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Basic	`EarningsPerShareBasic`	$0.57	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.62	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.57	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.62	USD	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Net income	`ProfitLoss`	$641.00M	USD	1 Quarter
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$305.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$480.00M	USD	1 Quarter
Venezuela impairment of net monetary assets	`VenezuelaRemeasurementImpact`	$14.00M	USD	1 Quarter
Venezuela impairment of net monetary assets	`VenezuelaRemeasurementImpact`	$246.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-189.00M	USD	1 Quarter
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$463.00M	USD	1 Quarter
Deferred Income Taxes Net And Uncertain Tax Positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-217.00M	USD	1 Quarter
Deferred Income Taxes Net And Uncertain Tax Positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-51.00M	USD	1 Quarter
Research and development in process	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
Research and development in process	`ResearchAndDevelopmentExpense`	$10.00M	USD	1 Quarter
Impairment of long lived assets	`AssetImpairmentCharges`	$11.00M	USD	1 Quarter
Impairment of long lived assets	`AssetImpairmentCharges`	$13.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$40.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$24.00M	USD	1 Quarter
Other items	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-7.00M	USD	1 Quarter
Other items	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-3.00M	USD	1 Quarter
Net gain from sale of long-lived assets and investments	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$39.00M	USD	1 Quarter
Net gain from sale of long-lived assets and investments	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	-	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$470.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.38B	USD	1 Quarter
Acquisitions of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.24B	USD	1 Quarter
Acquisitions of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$172.00M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$202.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAquireMarketableSecuritiesAndOtherAssets`	$6.00M	USD	1 Quarter
Purchases of investments and other assets	`PaymentToAquireMarketableSecuritiesAndOtherAssets`	$29.00M	USD	1 Quarter
Proceeds from sales of business, investments and long-lived assets	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.41B	USD	1 Quarter
Proceeds from sales of business, investments and long-lived assets	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.00M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-18.00M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$22.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.42B	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.18B	USD	1 Quarter
Proceeds from issuance of ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$329.00M	USD	1 Quarter
Proceeds from issuance of ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$329.00M	USD	1 Quarter
Proceeds from issuance of mandatory convertible preferred shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.35B	USD	1 Quarter
Net change in short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$38.00M	USD	1 Quarter
Dividends paid on ordinary shares	`PaymentsOfDividendsCommonStock`	$307.00M	USD	1 Quarter
Dividends paid on ordinary shares	`PaymentsOfDividendsCommonStock`	$346.00M	USD	1 Quarter
Dividends paid on preferred shares	`PaymentsOfDividendsPreferredStock`	$60.00M	USD	1 Quarter
Dividends paid on preferred shares	`PaymentsOfDividendsPreferredStock`	$65.00M	USD	1 Quarter
Proceeds from exercise of options by employees	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from exercise of options by employees	`ProceedsFromStockOptionsExercised`	$13.00M	USD	1 Quarter
Proceeds from long-term loans and other long-term liabilities, net of issuance costs	`ProceedsFromLongTermLoansAndOtherLongTermLiabilities`	-	USD	1 Quarter
Proceeds from long-term loans and other long-term liabilities, net of issuance costs	`ProceedsFromLongTermLoansAndOtherLongTermLiabilities`	$-3.00M	USD	1 Quarter
Repayment of long-term loans And Other Long Term Liabilities	`RepaymentsOfLongTermDebt`	-	USD	1 Quarter
Repayment of long-term loans And Other Long Term Liabilities	`RepaymentsOfLongTermDebt`	$41.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-31.00M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.00M	USD	1 Quarter
Net cash used in (provided by) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.77B	USD	1 Quarter
Net cash used in (provided by) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$267.00M	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-208.00M	USD	1 Quarter
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$28.00M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-982.00M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-88.00M	USD	1 Quarter
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$900.00M	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.96B	USD	Point-in-time
Balance of cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$900.00M	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$988.00M	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.96B	USD	Point-in-time
Balance of cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.95B	USD	Point-in-time

Comprehensive Income 19 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Net income	`ProfitLoss`	$641.00M	USD	1 Quarter
Net income	`ProfitLoss`	$633.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$255.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$466.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$336.00M	USD	1 Quarter
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-8.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$54.00M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-199.00M	USD	1 Quarter
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-13.00M	USD	1 Quarter
Unrealized gain (loss) on defined benefit plans	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	-	USD	1 Quarter
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$280.00M	USD	1 Quarter
Other Comprehensive Income (Loss)	`TotalOtherComprehensiveIncomeLoss`	$-515.00M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$1.16B	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$353.00M	USD	1 Quarter
Comprehensive income (loss) attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$66.00M	USD	1 Quarter
Comprehensive income (loss) attributable to non-controlling interests	`ComprehensiveLossAttributableToNonControllingInterests`	$-2.00M	USD	1 Quarter
Comprehensive income attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$355.00M	USD	1 Quarter
Comprehensive income attributable to Teva	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.